demonstrated that IGF2BP3 binds to m6A sites on HIF-1α mRNA in stomach cancer (SC) cells to positively modulate HIF-1α mRNA expression in an m6A-dependent manner and promote angiogenesis in SC through the IGF2BP3/HIF-1α pathway under hypoxic conditions (199). The gene discussed is HIF1A; the disease is gastric neoplasm.